Molecular determinants of acquired resistance to BRAF inhibition in human lung cancer

被引：1
|
作者：
Lucchesi, Carlo [1 ]
Drogat, Benjamin [2 ]
Santamaria, David
Cousin, Sophie [3 ]
Italiano, Antoine [1 ,3 ,4 ]
机构：
[1] Inst Bergonie, INSERM, U1218, 229 Cours Argonne, F-33076 Bordeaux, France
[2] Univ Bordeaux, INSERM, U1218, ACT Lab,IECB, F-33600 Pessac, France
[3] Inst Bergonie, Early Phase Trials Unit, 229 Cours Argonne, F-33076 Bordeaux, France
[4] Univ Bordeaux, Bordeaux, France
来源：
LUNG CANCER | 2018年 / 126卷
关键词：
D O I：
10.1016/j.lungcan.2018.10.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：227 / 229
页数：3
相关论文
共 50 条
  • [31] KRAS G12V Mutation in Acquired resistance to Combined BRAF and MEK Inhibition in Papilary Thyroid Cancer
    Owen, Dwight H.
    Konda, Bhavana
    Sipos, Jennifer
    Liu, Tom
    Webb, Amy
    Ringel, Matthew D.
    Timmers, Cynthia D.
    Shah, Manisha H.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (05): : 409 - 413
  • [32] Resistance to BRAF Inhibition in Melanomas
    Solit, David B.
    Rosen, Neal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (08): : 772 - 774
  • [33] Acquired resistance to EGFR inhibition: evolution from adenocarcinoma to small cell lung cancer (SCLC)
    Moss, C.
    Cane, R.
    Mclean, E.
    Santis, G.
    Tobal, K.
    Spicer, J.
    [J]. LUNG CANCER, 2013, 79 : S5 - S5
  • [34] MOLECULAR DETERMINANTS OF RESISTANCE TO TREATMENT WITH BRAF INHIBITORS AND INNOVATIVE POSSIBILITIES OF ITS OVERCOMING
    Kotowski, Krzysztof
    Supplitt, Stanislaw
    Saczko, Jolanta
    Kulbacka, Julita
    [J]. POSTEPY BIOLOGII KOMORKI, 2019, 46 (02) : 147 - 158
  • [35] BRAF and RAS mutations in human lung cancer and melanoma
    Brose, MS
    Volpe, P
    Feldman, M
    Kumar, M
    Rishi, I
    Gerrero, R
    Einhorn, E
    Herlyn, M
    Minna, J
    Nicholson, A
    Roth, JA
    Albelda, SM
    Davies, H
    Cox, C
    Brignell, G
    Stephens, P
    Futreal, PA
    Wooster, R
    Stratton, MR
    Weber, BL
    [J]. CANCER RESEARCH, 2002, 62 (23) : 6997 - 7000
  • [36] P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells
    Babagana, Mahamat
    Johnson, Sydney
    Slabodkin, Hannah
    Bshara, Wiam
    Morrison, Carl
    Kandel, Eugene S.
    [J]. MOLECULAR CARCINOGENESIS, 2017, 56 (05) : 1515 - 1525
  • [37] Molecular characterization of acquired resistance to KRASG12C-EGFR inhibition in colorectal cancer
    Misale, Sandra
    [J]. MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [38] Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR
    Della Corte, Carminia Maria
    Malapelle, Umberto
    Vigliar, Elena
    Pepe, Francesco
    Troncone, Giancarlo
    Ciaramella, Vincenza
    Troiani, Teresa
    Martinelli, Erika
    Belli, Valentina
    Ciardiello, Fortunato
    Morgillo, Floriana
    [J]. ONCOTARGET, 2017, 8 (14) : 23020 - 23032
  • [39] Acquired EGFR Exon 19 Deletion Is a Resistance Mechanism to BRAF/MRK Inhibition in BRAF V600Emutant NSCLC
    Wu, F.
    Liu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S479 - S480
  • [40] Molecular determinants of chemotherapy resistance in ovarian cancer
    Cooley, Megan
    Fang, Pingping
    Fang, Fang
    Nephew, Kenneth P.
    Chien, Jeremy
    [J]. PHARMACOGENOMICS, 2015, 16 (16) : 1763 - 1767
12345